Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo ...

Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health May 01, 2025 1:02 PM ET CVS Health Corporation (CVS) , NVO , LLY Q1: 2025-05-01 Earnings Summary ...